Clinical Trial Update: Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy? [NA]

View source ↗

Summary

Completed clinical trial evaluating HER2-targeted PET/CT imaging to identify unsuspected HER2-positive breast cancer metastases that may be eligible for HER2-ta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Cancer Metastases

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer Metastases, HER2 Positive Breast | NA | Status: COMPLETED | Results posted: 2021-06-18